Summary of Presentations from the Bristol Myers Squibb Symposium, held at the 49th Annual EASL ILC, London, UK, on 12th April 2014
Chairperson: Mark Thursz1
Speakers: Jean-Michel Pawlotsky,2 Heiner Wedemeyer,3 Ashley Brown,1 Charles Gore,4 Alessandra Mangia,5 Graham Foster,6 Rafael Esteban7
1. St Mary’s Hospital, London, UK
2. Henri Mondor Hospital, University of Paris-Est, Paris, France
3. Department of Gastroenterology, Hepatology and Endocrinology,
Hannover Medical School, Germany
4. World Hepatitis Alliance, Hepatitis C Trust
5. ‘Casa Sollievo della Sofferenza’ IRCCS, S. Giovanni Rotondo, Italy
6. Queen Mary, University of London, UK
7. Hospital Universitario Val d’Hebron, Barcelona, Spain
Disclosure: Speakers participating in this symposium received honorarium from Bristol Myers Squibb.
Acknowledgements: Writing assistance provided by Dr Jill Powell.
Support: The publication of this article was funded by Bristol Myers Squibb. The views and opinions expressed are those of the authors and not necessarily of Bristol Myers Squibb.
Citation: EMJ Hepatol. 2014;1:42-47.
This Bristol Myers Squibb-sponsored symposium was chaired by Mark Thursz, who oversaw a novel news bulletin-themed symposium with sessions provided by a distinguished, international team of roving reporters; Charles Gore from the World Hepatitis Alliance, Jean-Michel Pawlotsky from France, Alessandra Mangia from Italy, Ashley Brown and Graham Foster from London, Heiner Wedemeyer from Germany, and Rafael Esteban from Spain.